Orchard Therapeutics plc（ORTX）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ORTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2019-12	2018-12
Revenue
Revenue	$6.99M	$0.48M	$2.60M	$2.51M	$2.08M
Cost of Revenue	$2.43M	$0.23M	$0.86M	$0.81M	$0.42M
Gross Profit	$4.55M	$0.26M	$1.74M	$1.71M	$1.65M
Gross Margin %(computed)	65.17%	53.21%	66.97%	67.97%	79.67%
Operating Expenses
R&D Expenses	$25.55M	$23.35M	$93.73M	$117.36M	$205.32M
G&A Expenses	$44.66M	$49.65M	$56.89M	$49.16M	$0.00M
Total Operating Expenses	$36.15M	$36.90M	$158.72M	$174.58M	$236.69M
Operating Income	($31.59M)	($36.41M)	($156.98M)	($172.87M)	($235.03M)
Operating Margin %(computed)	-452.22%	—	—	—	—
Interest Income	$0.86M	$0.06M	$3.19M	$7.36M	$0.00M
Interest Expense	$0.93M	$0.68M	$2.33M	$1.54M	$0.00M
Income Before Tax	($9.01M)	($36.22M)	($152.71M)	($165.66M)	($229.53M)
Income Tax Expense	($1.13M)	$0.13M	($0.73M)	($2.24M)	$0.97M
Net Income	($7.88M)	($36.35M)	($151.98M)	($163.42M)	($230.50M)
Net Margin %(computed)	-112.84%	—	—	—	—
Per Share & EBITDA
EPS (Basic)	$-0.61	$-2.93	$-15.28	$-17.53	$-102.17
Wtd Avg Shares	12.80M	12.40M	9.94M	9.32M	2.26M
EBITDA	($8.08M)	($35.54M)	($148.38M)	($155.38M)	($235.03M)
EBITDA Margin %(computed)	-115.65%	—	—	—	—